Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
RSLS on Nasdaq
Thomas Stankovich - trading volume in the past year for ReShape Lifesciences Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock, $0.001 par value per share |
22.9K |
$6.2K |
$0.27 |
Oct 25, 2023 |
Direct |
|
|
Common Stock, $0.001 par value per share |
22.8K |
$5.69K |
$0.25 |
May 31, 2024 |
Direct |
|
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.